--- title: "Bioventus (BVS) stock listing, news and investor profile" url: "https://aibio.space/companies/bioventus/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Bioventus Inc. (NASDAQ: BVS), United States. Listing facts, related biotech companies and news on aibio.space." --- BVS Bioventus Inc. NASDAQ · United States # Bioventus (BVS) news Bioventus Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BVS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Bioventus news We have not published a story on Bioventus yet. When there is news, it will appear here. ## Bioventus at a glance - **Ticker**: BVS - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 27, 2026**: $29.5 million ### Related companies - [electroCore](https://aibio.space/companies/electrocore/) NASDAQ: ECOR - [EXOZYMES INC.](https://aibio.space/companies/exozymes/) NASDAQ: EXOZ - [VivoSim Labs, INC.](https://aibio.space/companies/vivosim-labs/) NASDAQ: VIVS - [Beroni Group](https://aibio.space/companies/beroni/) OTC: BNIGF - [Tenon Medical](https://aibio.space/companies/tenon-medical/) NASDAQ: TNON - [Medpace Holdings](https://aibio.space/companies/medpace/) NASDAQ: MEDP - [Mobia Medical](https://aibio.space/companies/mobia-medical/) NASDAQ: MOBI - [QIAGEN](https://aibio.space/companies/qiagen-n-v/) NYSE: QGEN ### Also on NASDAQ - [HCW Biologics](https://aibio.space/companies/hcw-biologics/) HCWB - [Envoy Medical](https://aibio.space/companies/envoy-medical/) COCH - [Processa Pharmaceuticals](https://aibio.space/companies/processa-pharmaceuticals/) PCSA - [TransMedics Group](https://aibio.space/companies/transmedics/) TMDX - [Revelation Biosciences](https://aibio.space/companies/revelation-biosciences/) REVB - [Innoviva](https://aibio.space/companies/innoviva/) INVA ## Bioventus annual financials | Line | FY2025 | FY2024 | |---|---|---| | Revenue | [$568.1 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/) | [$573.3 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/) | | Research and development | [$12.1 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/) | [$14.0 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/) | | Net income (loss) | [$22.7 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/) | [-$36.1 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/) | | Cash from operations | [$74.7 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/) | [$38.8 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/) | | Cash and equivalents | [$51.2 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000042/) | [$41.6 million](https://www.sec.gov/Archives/edgar/data/1665988/000166598826000011/) | Latest balance sheet, Jun 27, 2026 (10-Q): cash and equivalents $29.5 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Bioventus What is the ticker symbol of Bioventus? Bioventus Inc. trades under the ticker BVS on NASDAQ. Where is Bioventus listed? Bioventus Inc. is listed on NASDAQ. Which country or territory is Bioventus listed under? Our directory records Bioventus Inc. under United States. Does aibio.space cover Bioventus? aibio.space lists Bioventus Inc. among 2,820 public biotech companies and publishes its news here as stories appear. What was Bioventus's revenue last year? $568.1 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Bioventus profitable? Bioventus Inc. reported net income of $22.7 million for the fiscal year ended Dec 31, 2025, and generated $74.7 million of cash from operations, per its annual report to the SEC. How much does Bioventus spend on research and development? $12.1 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Bioventus have? $29.5 million in cash at Jun 27, 2026, per its 10-Q. ## Investor discussion: Bioventus Members talk about Bioventus (BVS). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:BVS on TradingView](https://www.tradingview.com/symbols/NASDAQ-BVS/). ## Listing details Bioventus Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker BVS, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Bioventus Inc. - **Ticker**: BVS - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/bioventus/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Bioventus (BVS) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/bioventus/